These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24462212)
1. Limonene inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal function and dopamine release. Yun J Phytomedicine; 2014 May; 21(6):883-7. PubMed ID: 24462212 [TBL] [Abstract][Full Text] [Related]
2. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression. Yun J Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791 [TBL] [Abstract][Full Text] [Related]
3. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. Izawa J; Yamanashi K; Asakura T; Misu Y; Goshima Y Eur J Pharmacol; 2006 Nov; 549(1-3):84-90. PubMed ID: 16979160 [TBL] [Abstract][Full Text] [Related]
6. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Broderick PA; Olabisi OA; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963 [TBL] [Abstract][Full Text] [Related]
7. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study. Steed E; Jones CA; McCreary AC Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272 [TBL] [Abstract][Full Text] [Related]
8. Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats. Zhou W; Yoshioka M; Yokogoshi H J Nutr Sci Vitaminol (Tokyo); 2009 Aug; 55(4):367-73. PubMed ID: 19763039 [TBL] [Abstract][Full Text] [Related]
9. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654 [TBL] [Abstract][Full Text] [Related]
10. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effects of nicotine and methamphetamine on extracellular dopamine in the nucleus accumbens of behaviorally sensitized rats]. Miyata H; Ando K; Yanagita T Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Apr; 16(2):41-7. PubMed ID: 8905789 [TBL] [Abstract][Full Text] [Related]
12. Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation. Suzuki T; Shindo K; Miyatake M; Kurokawa K; Higashiyama K; Suzuki M; Narita M Eur J Pharmacol; 2007 Nov; 574(1):39-48. PubMed ID: 17869241 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice. Miyamoto Y; Iida A; Sato K; Muramatsu S; Nitta A Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522385 [TBL] [Abstract][Full Text] [Related]
14. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens. Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190 [TBL] [Abstract][Full Text] [Related]
15. The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats. Mizuno M; Kawamura H; Ishizuka Y; Sotoyama H; Nawa H Pharmacol Biochem Behav; 2010 Dec; 97(2):392-8. PubMed ID: 20863847 [TBL] [Abstract][Full Text] [Related]
16. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release. Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792 [TBL] [Abstract][Full Text] [Related]
17. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice. Yoo JH; Nam YS; Lee SY; Jang CG Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891 [TBL] [Abstract][Full Text] [Related]
18. Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels. Mills K; Arsah TA; Ali SF; Shockley DC Ann N Y Acad Sci; 1998 May; 844():201-7. PubMed ID: 9668678 [TBL] [Abstract][Full Text] [Related]
19. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine. Chen NH; Reith ME J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Qi J; Yang JY; Song M; Li Y; Wang F; Wu CF Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):441-8. PubMed ID: 18092152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]